Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 25, 2013
Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiationF McDonald, S Lalondrelle, H Taylor, et al.
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2009
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)L R Molife, G Attard, P C Fong, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 1, 2017
Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planningF Guerreiro, N Burgos, A Dunlop, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2008
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experienceD Olmos, H-T Arkenau, J E Ang, et al.
British Journal of Cancer|July 29, 2004
ATM polymorphisms as risk factors for prostate cancer developmentS Angèle, A Falconer, S M Edwards, et al.
British Journal of Cancer|December 2, 2010
Hand pattern indicates prostate cancer riskA A Rahman, A Lophatananon, S Stewart-Brown, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
High risk genes predisposing to prostate cancer development-do they exist?R Singh, R A Eeles, F Durocher, et al.
Pageof 6